148 related articles for article (PubMed ID: 7596061)
1. [Plasma concentration of cytosine arabinoside (Ara-C) in the elderly patients with hematological malignancy treated by Ara-C or cytarabine ocfosfate (SPAC)].
Tsutsumi H; Kumakawa T; Hirai M; Kikukawa M; Arie Y; Mori M; Kodo H; Nakamura N; Murai Y; Mizutani R
Nihon Ronen Igakkai Zasshi; 1995 Mar; 32(3):190-4. PubMed ID: 7596061
[TBL] [Abstract][Full Text] [Related]
2. [A pharmacokinetic study of the value of oral cytarabine ocfosfate in the treatment of hematological malignancies].
Ueda Y; Mori S; Ito T; Maesako Y; Konishi H; Yagiri Y
Rinsho Ketsueki; 1998 May; 39(5):348-54. PubMed ID: 9637884
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of Ara-CMP-Stearate (YNK01): phase I study of the oral Ara-C derivative.
Schleyer E; Braess J; Ramsauer B; Unterhalt M; Kaufmann C; Wilde S; Schüssler M; Hiddemann W
Leukemia; 1995 Jun; 9(6):1085-90. PubMed ID: 7596174
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate, an orally administered long-acting derivative of low-dose 1-beta-D-arabinofuranosylcytosine.
Ueda T; Kamiya K; Urasaki Y; Wataya S; Kawai Y; Tsutani H; Sugiyama M; Nakamura T
Cancer Res; 1994 Jan; 54(1):109-13. PubMed ID: 8261429
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acute myeloid leukemia and myelodysplastic syndrome with orally administered cytarabine ocfosfate and granulocyte colony-stimulating factor.
Okumura H; Yoshida T; Takamatsu H; Katoh T; Murashima M; Watanabe A; Yamauchi H; Matano S; Chuhjo T; Takeshima M; Kaya H; Ohtake S; Nakamura S; Matsuda T
Int J Hematol; 1997 Apr; 65(3):263-8. PubMed ID: 9114597
[TBL] [Abstract][Full Text] [Related]
6. [A new antileukemic drug, cytarabine ocfosfate].
Tsukagoshi S
Gan To Kagaku Ryoho; 1993 Sep; 20(12):1877-83. PubMed ID: 8379682
[TBL] [Abstract][Full Text] [Related]
7. [Successful treatment of acute myelogenous leukemia in an elderly patient with cytarabine ocfosfate].
Inaba T; Shimazaki C; Tatsumi T; Yamagata N; Hirata T; Goto H; Fujita N; Nakagawa M; Fujita N; Miyazaki S
Gan To Kagaku Ryoho; 1994 Mar; 21(4):535-8. PubMed ID: 8129396
[TBL] [Abstract][Full Text] [Related]
8. [Low-dose cytarabine ocfosfate therapy in an elderly acute myelogenous leukemia].
Hamaoka R; Jozaki K; Amano T; Itoh H; Imai Y; Nishikawa M; Kurokawa M; Yonezawa T; Chinen Y
Gan To Kagaku Ryoho; 1995 May; 22(6):819-22. PubMed ID: 7755392
[TBL] [Abstract][Full Text] [Related]
9. [Therapy-related acute non-lymphocytic leukemia (M2) with 7;11 chromosome translocation induced into complete remission by low dose cytosine arabinoside and cytarabine ocfosfate therapy].
Shikoshi K; Shikoshi K; Niitsu N; Takada M; Umeda M
Nihon Ronen Igakkai Zasshi; 1994 Jun; 31(6):468-71. PubMed ID: 8078212
[TBL] [Abstract][Full Text] [Related]
10. [Successful treatment of acute myelomonocytic leukemia developed from MDS with cytarabine ocfosfate (SPAC)].
Wake A; Takazawa A; Serino Y; Tonai S; Nakanishi M; Murakami S; Ogawa R; Nagata K; Mori N; Nakata K
Gan To Kagaku Ryoho; 1995 Feb; 22(3):395-8. PubMed ID: 7880111
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of refractory hematologic malignancies by combination of cytarabine ocfosfate and etoposide].
Kiyama Y; Suzuki G; Masauzi N; Ohizumi H; Kobayashi N; Ogasawara M; Naohara T; Saito M; Higa T; Kasai M
Gan To Kagaku Ryoho; 1996 Oct; 23(12):1717-20. PubMed ID: 8886052
[TBL] [Abstract][Full Text] [Related]
12. [A case of complete remission from acute unclassified leukemia achieved by using a prodrug of ara C, stearyl-ara-CMP (YNK01)].
Nishikawa M; Morita K; Komada F; Uemura Y; Kageyama S; Minami N; Deguchi K; Shirakawa S
Gan No Rinsho; 1990 Oct; 36(12):2204-9. PubMed ID: 2232191
[TBL] [Abstract][Full Text] [Related]
13. Oral cytarabine ocfosfate in acute myeloid leukemia and non-Hodgkin's lymphoma--phase I/II studies and pharmacokinetics.
Braess J; Freund M; Hanauske A; Heil G; Kaufmann C; Kern W; Schüssler M; Hiddemann W; Schleyer E
Leukemia; 1998 Oct; 12(10):1618-26. PubMed ID: 9766508
[TBL] [Abstract][Full Text] [Related]
14. [Phase I study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate)].
Fukuoka M; Miyazaki T; Yoshida Y; Hattori M; Niitani H; Nakamura T; Hirota Y; Ohta K; Tanaka M; Suzuoki Y
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2213-9. PubMed ID: 2241185
[TBL] [Abstract][Full Text] [Related]
15. The value of oral cytarabine ocfosfate and etoposide in the treatment of refractory and elderly AML patients.
Horikoshi A; Takei K; Hosokawa Y; Sawada S
Int J Hematol; 2008 Mar; 87(2):118-125. PubMed ID: 18228114
[TBL] [Abstract][Full Text] [Related]
16. [Five cases of myelodysplastic syndrome treated with cytarabine ocfosfate].
Nishi T; Funasako M; Hata N; Andoh K; Itoh Y; Ono H; Itoh K; Sato Y; Sato H; Taniji M; Nakai S; Ueda A; Fujimoto H; Ohata M
Gan To Kagaku Ryoho; 1996 Sep; 23(10):1331-4. PubMed ID: 8831748
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of oral cytarabine ocfosfate and etoposide in the treatment of elderly patients with higher-risk myelodysplastic syndromes compared to that in elderly acute myeloid leukemia patients.
Horikoshi A; Iriyama N; Hirabayashi Y; Kodaira H; Matsukawa Y; Uchino Y; Takahashi H; Hatta Y; Takeuchi J; Kobayashi S; Miura K
Chemotherapy; 2013; 59(2):152-8. PubMed ID: 24080768
[TBL] [Abstract][Full Text] [Related]
18. [Oral administration of cytarabine ocfosfate and ondansetron hydrochloride in patients with acute myeloid leukemia who can not be treated with intensive chemotherapy:--attempt to make their quality of life better].
Yano K; Matsui H; Fujisawa S
Gan To Kagaku Ryoho; 1998 Feb; 25(3):427-30. PubMed ID: 9492840
[No Abstract] [Full Text] [Related]
19. A severe hepatic disorder with myelodysplastic syndrome, treated with cytarabine ocfosfate, in a dog.
Ide K; Momoi Y; Minegishi M; Sekiguchi M; Konno K; Iwasaki T
Aust Vet J; 2003; 81(1-2):47-9. PubMed ID: 15084010
[TBL] [Abstract][Full Text] [Related]
20. [Relation between plasma Ara-C and intracellular Ara-CTP levels by intermediate dose and high dose Ara-C administration in the treatment of AML].
Yoshida T; Kobayashi K; Nakamura S; Ohtake S; Itoh K; Kanno M; Hirai J; Yasushi ; Matsuda TT
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):625-30. PubMed ID: 3162669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
